TCI Wealth Advisors’s Nutex Health NUTX Stock Holding History

TCI Wealth Advisors’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8	Closed	-$2K	–	2603
2022 Q3	$2K	Buy	+8	New	+$3.39K	﹤0.01%	1959

Other funds holding NUTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

TCI Wealth Advisors's NUTX Position: Q4 2022 in Review

TCI Wealth Advisors sold out of Nutex Health (NUTX) in Q4 2022, closing a stake of 8 shares — an estimated $2K sold.

TCI Wealth Advisors first reported a position in NUTX in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 76 funds tracked by Wall St. Rank hold NUTX as of Q4 2022.

TCI Wealth Advisors reported no remaining Nutex Health position as of Q4 2022 after selling out during the quarter.
TCI Wealth Advisors sold 8 Nutex Health shares in Q4 2022, an estimated $2K.
TCI Wealth Advisors first reported a position in Nutex Health in Q3 2022 and held it in 1 quarter.
TCI Wealth Advisors's Nutex Health position peaked at $2K in Q3 2022.
76 funds tracked by Wall St. Rank held Nutex Health as of Q4 2022.

Based on TCI Wealth Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.